Word

DAYBREAK

Status

Dead

Status Code

710

Status Date

Friday, February 2, 2024

Serial Number

87197710

Registration Number

5244577

Registration Date

Tuesday, July 18, 2017

Mark Type

4000

Filing Date

Monday, October 10, 2016

Published for Opposition

Tuesday, May 2, 2017

Cancellation Date

Friday, February 2, 2024

Trademark Owner History

H. Lundbeck A-S - Original Registrant

Classifications

5 Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, stroke, depression, cognitive, mood disorders, psychosis, anxiety, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, ADHD, cancer, pain, alcoholism and chemical dependency; diagnostic agents, reagents, preparations and substances for medical purposes

42 Scientific and technological services, namely, research and design relating thereto in the field of science, medicine and pharmaceuticals regarding the treatment of schizophrenia; conducting clinical studies, tests and trials for others in the fields of science, medicine and pharmaceuticals regarding the treatment of schizophrenia; industrial analysis and research services in the field of science, medicine and pharmaceuticals regarding the treatment of schizophrenia; pharmaceutical and medical research and development regarding the treatment of schizophrenia; medical and clinical and diagnostic research, studies, tests and trials in the field of science, medicine and pharmaceuticals regarding the treatment of schizophrenia and providing information in the field of research and development of pharmaceuticals for the treatment of schizophrenia

Trademark Events

Feb 2, 2024

Cancelled Sec. 8 (6-Yr)

Jul 18, 2022

Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed

Jul 18, 2017

Registered-Principal Register

May 2, 2017

Official Gazette Publication Confirmation E-Mailed

May 2, 2017

Published For Opposition

Apr 12, 2017

Notification Of Notice Of Publication E-Mailed

Mar 27, 2017

Law Office Publication Review Completed

Mar 15, 2017

Approved For Pub - Principal Register

Feb 23, 2017

Teas/Email Correspondence Entered

Feb 23, 2017

Correspondence Received In Law Office

Feb 12, 2017

Assigned To Lie

Jan 30, 2017

Teas Response To Office Action Received

Dec 20, 2016

Notification Of Non-Final Action E-Mailed

Dec 20, 2016

Non-Final Action E-Mailed

Dec 20, 2016

Non-Final Action Written

Dec 19, 2016

Assigned To Examiner

Oct 14, 2016

New Application Office Supplied Data Entered

Oct 13, 2016

New Application Entered